<DOC>
	<DOC>NCT00492635</DOC>
	<brief_summary>A study to assess the efficacy of vardenafil, taken as a tablet both nightly or 'as needed' (immediately before intended sexual activity) compared to placebo, to evaluate its tolerability and if it can help in recovery of erections after a nerve sparing radical prostatectomy.</brief_summary>
	<brief_title>Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sexual Dysfunction, Physiological</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>At Screening Males 1864 years of age Scheduled to undergo bilateral nervesparing radical retropubic BNSRRP, as selected according to the investigator's usual clinical practice Surgery scheduled within about 1 month of screening (Visit 1) Expressed an interest in resuming sexual activity as soon as possible after prostatectomy Heterosexual relationship No preoperative erectile dysfunction: International Index of Erectile Function (IIEF) Erectile Function Domain Score score EF domain =26 at screening without any therapy/devices for improvement of erections No perforation of the prostate capsule by tumor At Randomization: Before being randomized subjects must still be meeting all Screening Inclusion Criteria, as well as the following criteria: bilateral nervesparing during the retropubic prostatectomy documented on the operating report BNSRRP occurred within approximately 1 month post screening (Visit 1) No perforation of the prostate capsule by tumor: No positive tumor margins confirmed after surgery: =T2 stage on pathology report from the surgery Subjects who are taking nitrates or nitric oxide donors Subjects who are taking the following inhibitors of cytochrome P 450 CYP 3A4: very potent HIV protease inhibitors (ritonavir, indinavir), the antimycotic agents itraconazole and ketoconazole (topical forms are allowed) or erythromycin Known hypersensitivity to Vardenafil Presence of significant penile anatomical abnormalities (e.g. penile fibrosis or Peyronie's disease) History of retinitis pigmentosa Unstable angina pectoris History of myocardial infarction, stroke or lifethreatening arrhythmia within the prior 6 months Severe chronic or acute liver disease Symptomatic postural hypotension in the past 6 months NYHA Class III or IV heart failure Life expectancy &lt;3 years Clinical diagnosis of significant untreated sleep apnea or working night shifts (e.g. 23:00h to 7:00 h) Antiandrogens use Residual prostate cancer, or requirement for radiotherapy or ADT after surgery</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>